Volume 13, Issue 2 (3-2023)                   PCNM 2023, 13(2): 1-7 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Fatahzadeh-Ardalani G, Darghahi R, Amani F, Peighambari M. Outcomes of Pregnancy in Women with Epilepsy in Ardabil. PCNM 2023; 13 (2) :1-7
URL: http://nmcjournal.zums.ac.ir/article-1-861-en.html
Outcomes of Pregnancy in Women with Epilepsy in Ardabil
Ghasem Fatahzadeh-Ardalani , Roghayeh Darghahi , Firouz Amani * , Mohsen Peighambari
Department of Community Medicine, school of medicine, Ardabil University of Medical Sciences, Ardabil, Iran , biostat.f@gmail.com
Abstract:   (973 Views)
Background: Epilepsy is the second, most common and most dangerous neurological complication that can occur in a pregnant woman. Women with epilepsy (WWE) are at higher risk for miscarriage, prematurity, congenital anomalies and low birth weight (LBW).
Objectives: The aim of this study was to investigate the outcome of pregnancy in women with epilepsy.
Methods: This descriptive study was conducted on 131 pregnant women with epilepsy who referred to Ardabil Alavi Hospital from September 2019 to September 2021. Necessary information such as BMI, type of seizure, congenital malformation, treatment drug and name of used drugs collected through patients file by a checklist and then analyzed by using statistical methods in SPSS version 25.
Results: The frequency of neonate term birth was 83.21% and preterm birth was 16.79%. The frequency of babies with LBW was 22.85%. Most of women with 65.96% had cesarean delivery. More than 83% of seizures were generalized and 67.93% used mono-therapy. Only one fetus had malformation (0.76%). The most frequency among the patients receiving mono-therapy was related to the carbamazepine with 26.71% and among the women treated with multitherapy was related to Levetiracetam plus carbamazepine with 12.97%.
Conclusion: Pregnancies with epilepsy, even in cases with multidisciplinary care and no other risk factors, are still significantly associated with higher adverse outcomes.

 
Keywords: epilepsy, seizures, pregnancy, birth defects, malformation
Full-Text [PDF 543 kb]   (863 Downloads)    
Type of Study: Orginal research | Subject: Midwifery
Received: 2023/01/15 | Accepted: 2023/03/1 | Published: 2023/03/1
References
1. 1. AlSheikh MH. Prevalence of epilepsy in Saudi pregnant women and possible effects of anti-epileptic drugs on pregnancy outcomes. Neurosciences (Riyadh). 2020 Jan; 25(1): 32-37.10.17712/nsj.2020.1.20190077[doi: 10.17712/nsj.2020.1.20190077]. PMID: 31982897; PMCID:PMC8015625.10.17712/nsj.2020.1.20190077 []
2. Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon CS, Dykeman J, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology. 2017 Jan 17;88(3):296-303. [doi: 10.1212/WNL.0000000000003509]. [crossref]
3. Motha MBC, Palihawadana TS, Jayasinghe C, Ranawaka UK. Seizure patterns, preconception care and pregnancy outcomes in women with epilepsy in a tertiary care hospital. J C C P. 2020; 51(Sup 1): 8.
4. Shihman B, Goldstein L, Amiel N, Benninger F. Antiepileptic drug treatment during pregnancy and delivery in women with epilepsy-a retrospective single center study. Epilepsy Res. 2019; 149: 66-9. [crossref]
5. Viale L, Allotey J, Cheong-See F, Arroyo-Manzano D, Mccorry D, Bagary M, et al. EBM CONNECT Collaboration. Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis. Lancet. 2015. 10.1016/S0140-6736(15)00045-8.386(10006): 1845-52.[doi: 10.1016/S0140-6736(15)00045-8]. Epub 2015 Aug 25. PMID: 26318519. 10.1016/S0140-6736(15)00045-8 []
6. Galappatthy P, Liyanage CK, Lucas MN, Jayasekara DTLM, Abhayaratna SA, Weeraratne C, et al. Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study. BMC Pregnancy Childbirth. 2018; 18(1): 230.[doi: 10.1186/s12884-018-1857-3]. PMID: 29898689; PMCID: PMC6000926. [crossref]
7. Veroniki AA, Cogo E, Rios P, Straus SE, Finkelstein Y, Kealey R, et al. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med. 2017; 15(1):95. [doi: 10.1186/s12916-017-0845-1]. PMID: 28472982; PMCID: PMC5418725. [crossref]
8. Bosak M, Song BH, Dewerenda-Sikora M, Słowik A, Lasek-Bal A. Obstetric and neonatal outcomes in women with epilepsy in Poland - a two-centre study. Neurol Neurochir Pol. 2020;54(1):62-65. [doi: 10.5603/PJNNS.a2020.0003]. Epub 2020 Jan 20. PMID: 31956972. [crossref]
9. Razaz N, Tomson T, Wikström AK, et al. Association Between Pregnancy and Perinatal Outcomes Among Women with Epilepsy. JAMA Neurol. 2017; 74(8): 983-991, [doi: 10.1001/jamaneurol.2017.1310]. indexed in Pubmed: 28672292. [crossref]
10. Melikova S, Bagirova H, Magalov S. The impact of maternal epilepsy on delivery and neonatal outcomes. Childs Nerv Syst. 2020 Apr.10.1007/s00381-019-04435-236(4):775-782. [doi: 10.1007/s00381-019-04435-2]. Epub 2019 Nov 30. PMID: 31786631.10.1007/s00381-019-04435-2 []
11. Huang CY, Dai YM, Feng LM, Gao WL. Clinical characteristics and outcomes in pregnant women with epilepsy. Epilepsy Behav. 2020 10.1016/j.yebeh.2020.107433112: 107433. [doi: 10.1016/j.yebeh.2020.107433]. Epub 2020 Sep 9. PMID: 32919204. 10.1016/j.yebeh.2020.107433 []
12. Soontornpun A, Choovanichvong T, Tongsong T. Pregnancy outcomes among women with epilepsy: A retrospective cohort study. Epilepsy Behav. 2018 May 10.1016/j.yebeh.2018.03.00182: 52-56. [doi: 10.1016/j.yebeh.2018.03.001]. Epub 2018 Mar 24. PMID: 29587185. 10.1016/j.yebeh.2018.03.001 []
13. Kang MJ, Chung HR, Oh YJ, Shim YS, Yang S, Hwang IT. Three-year follow-up of children with abnormal newborn screening results for congenital hypothyroidism. Pediatr Neonatol. 2017 Oct;58(5):442-448. [doi: 10.1016/j.pedneo.2017.01.002]. Epub 2017 Mar 27. PMID: 28412200. [crossref]
14. Shahid R, Nazish S, Zafar A, Aljafaari D, Alabdali M, Ishaque N, et al. Epidemiological study of epilepsy from a tertiary care hospital in kingdom of Saudi Arabia. Neurosciences (Riyadh). 2018; 23(3): 223-6. [doi: 10.17712/nsj.2018.3.20180062]. PMID: 30007998; PMCID: PMC8015582. [crossref]
15. Aydın E, Beksaç MS. Retrospective Evaluation of Pregnancy Outcomes with Maternal Epilepsy. J Clin Obstet Gynecol. 2020; 30(1): 20-5. [crossref]
16. Routier L, Verny F, Barcia G, Chemaly N, Desguerre I, Colleaux L, et al. Exome sequencing findings in 27 patients with myoclonic-atonic epilepsy: Is there a major genetic factor? Clin Genet. 2019.10.1111/cge.1358196(3): 254-260. [doi: 10.1111/cge.13581]. Epub 2019 Jun 6. PMID: 31170314. 10.1111/cge.13581 []
17. Chen D, Hou L, Duan X, Peng H, Peng B. Effect of epilepsy in pregnancy on fetal growth restriction: a systematic review and meta-analysis. Arch Gynecol Obstet. 2017.10.1007/s00404-017-4404-y.296(3):421-7. [doi: 10.1007/s00404-017-4404-y]. Epub 2017 Jun 23. PMID: 28646257. 10.1007/s00404-017-4404-y []
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Preventive Care in Nursing & Midwifery Journal

Designed & Developed by : Yektaweb